Sodium Hydroxide → HCID 86698047, compound
Reaction equation
[OH-].[Na+].Cl.[NH:4]1[CH2:9][CH2:8][CH:7]([C:10]2[CH:14]=[C:13]([NH:15][C:16]3[N:17]=[CH:18][C:19]4[S:24][C:23]([C:25]([NH2:27])=[O:26])=[C:22]([C:28]5[CH:33]=[CH:32][CH:31]=[CH:30][C:29]=5[O:34][C:35]([F:38])([F:37])[F:36])[C:20]=4[N:21]=3)[N:12]([CH:39]([CH3:41])[CH3:40])[N:11]=2)[CH2:6][CH2:5]1>C(OCC)(=O)C>[NH:4]1[CH2:5][CH2:6][CH:7]([C:10]2[CH:14]=[C:13]([NH:15][C:16]3[N:17]=[CH:18][C:19]4[S:24][C:23]([C:25]([NH2:27])=[O:26])=[C:22]([C:28]5[CH:33]=[CH:32][CH:31]=[CH:30][C:29]=5[O:34][C:35]([F:36])([F:37])[F:38])[C:20]=4[N:21]=3)[N:12]([CH:39]([CH3:41])[CH3:40])[N:11]=2)[CH2:8][CH2:9]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
10 ml of 1N sodium hydroxide are added to a solution of 50 mg of 2-{[3-(piperidin-4-yl)-1-(propan-2-yl)-1H-pyrazol-5-yl]amino}-7-[2-(trifluoromethoxy)phenyl]thieno[3,2-d]pyrimidine-6-carboxamide hydrochloride in 10 ml of ethyl acetate. The mixture is stirred, and then the aqueous phase is extracted twice with 30 ml of ethyl acetate. The combined organic phases are dried over magnesium sulfate, filtered and concentrated under vacuum, so as to obtain 42 mg of 2-{[3-(piperidin-4-yl)-1-(propan-2-yl)-1H-pyrazol-5-yl]amino}-7-[2-(trifluoromethoxy)phenyl]thieno[3,2-d]pyrimidine-6-carboxamide.
Workup
- extractionthe aqueous phase is extracted twice with 30 ml of ethyl acetate
- dry with materialThe combined organic phases are dried over magnesium sulfate
- filtrationfiltered
- concentrationconcentrated under vacuum
Sources & evidence
- ORD record
- ord-14b1702bf2cf46a082bb4b300499ca51
- Source dataset
- uspto-grants-2015_08
- Patent number
- US09115140B2
Reaction notes
Loading…